A new study being published in next month’s issue of the journal Atherosclerosis, and published online early by the National Institute of Health, has found that activation of the body’s cannabinoid receptors – something done naturally by cannabis – may provide a potential treatment option for atherosclerosis.
Atherosclerosis, also known as vascular disease, is a fairly common disorder that occurs when substances such as fat or cholesterol build up in the walls of arteries, forming plaques. Over time, this process can block the arteries and cause severe problems throughout the body.
According to the study; “A fully active ECS [endocannabinoid system] is present in human macrophages and macrophage-derived foam cells. Selective activation of CB2R [type-2 cannabinoid receptor] reduces CD36-dependent oxLDL accumulation and modulates production of inflammatory cytokines, thus representing a potential therapeutic strategy to combat atherosclerosis.”
The study – which can be found by clicking here – is one of the first to detail how cannabinoid receptor activation may provide an effective treatment option for those with atherosclerosis.